Show
Sort by
-
Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer
-
- Book Chapter
- open access
Questioning the pathogenic role of the GLA p.Ala143Thr 'mutation' in Fabry disease: implications for screening studies and ERT
-
Prevalence of Fabry disease in a predominantly hypertensive population with left ventricular hypertrophy
-
Prevalence of BRCA1/2 mutations in sporadic breast/ovarian cancer patients and identification of a novel de novo BRCA1 mutation in a patient diagnosed with late onset breast and ovarian cancer: implications for genetic testing
-
Evaluation of RAD51C as cancer susceptibility gene in a large breast-ovarian cancer patient population referred for genetic testing
-
- Journal Article
- A1
- open access
Association of PHB 1630 C > T and MTHFR 677 C > T polymorphisms with breast and ovarian cancer risk in BRCA1/2 mutation carriers: results from a multicenter study
-
EVI1-mediated down regulation of MIR449A is essential for the survival of EVI1 positive leukaemic cells
-
Evaluation of RAD51C as a new breast cancer suceptibility gene in Belgian/Dutch population
-
Massive parallel amplicon sequencing of the breast cancer genes BRCA1 and BRCA2: opportunities, challenges, and limitations
-
The relationship between genetic testing, psychological well-being and surveillance behavior: a questionnaire study in presymptomatic female and male BRCA carriers and non-carriers